Jessica Nichols
Family · Pilot Knob, MONPI 1760058739
Payments from drug & device makers
Across 92 payments — averaging $20.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$505
- Johnson & Johnson$256
- AstraZeneca$180
- Amgen$130
- Biohaven Pharmaceuticals, Inc.$114
- Sandoz$104
- plus $580 from 14 others
What the payments were for
- Food & beverage$1,67790%
- Education$1769%
- Entertainment$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $505 |
| Johnson & Johnson | 6 | $256 |
| AstraZeneca(2 entities) | 10 | $180 |
| Amgen | 8 | $130 |
| Biohaven Pharmaceuticals, Inc. | 3 | $114 |
| Sandoz | 4 | $104 |
| Lilly USA, LLC | 6 | $99 |
| UCB, Inc. | 4 | $83 |
| Organon | 9 | $80 |
| Mallinckrodt Hospital Products Inc. | 3 | $66 |
| GSK | 3 | $60 |
| Xeris Pharmaceuticals, Inc. | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Qiagen, LLC | 1 | $19 |
| Exact Sciences | 1 | $19 |
| Boehringer Ingelheim | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $17 |
| Optos, Inc. | 1 | $17 |
| Grifols USA, LLC | 1 | $15 |
| Novartis | 1 | $12 |
How this compares
$1,870 in reported general payments places this provider in the 75th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 16 | $114,810 |
| OzempicSemaglutide | 47 | $48,187 |
| JardianceEmpagliflozin | 47 | $41,559 |
| EliquisApixaban | 65 | $37,184 |
| VraylarCariprazine Hcl | 26 | $36,837 |
| FarxigaDapagliflozin Propanediol | 52 | $35,159 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 38 | $31,663 |
| Breo ElliptaFluticasone/Vilanterol | 43 | $23,778 |
| MounjaroTirzepatide | 15 | $21,442 |
| TrulicityDulaglutide | 17 | $16,916 |
| JanuviaSitagliptin Phosphate | 15 | $10,061 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $9,613 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $8,168 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 11 | $7,584 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 23 | $4,969 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $60 | $63,60993 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $18 | $49,14358 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $180 | $47,41879 claims |
| Lilly USA, LLCMounjaro, Trulicity | $99 | $38,35932 claims |
| AbbVieVraylar | $505 | $36,83726 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,812 family providers in Missouri.
Other family in Pilot Knob
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.